AirXpanders Incorporated (ASX:AXP)
has reported strong market growth for the national launch of its AeroForm product in Australia.
AirXpanders announced an almost 10 percent gain in market share in the first 90 days since AeroForm’s launch in Australia in July this year.
The medical devices company has actively engaged 20 major private and public hospitals and has also trained more than 50 surgeons in the use of Aeroform.
The company noted it is continuing its preparations to enter the US market.
AirXpanders recorded a net loss of $5.98 million for the half year to 30 June 2015.